ORI
ALXN

Oak Ridge Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-28,334
Closed -$5.21M 178
2021
Q2
$5.21M Sell
28,334
-596
-2% -$110K 0.45% 78
2021
Q1
$4.42M Buy
28,930
+182
+0.6% +$27.8K 0.41% 91
2020
Q4
$4.49M Sell
28,748
-13,011
-31% -$2.03M 0.4% 94
2020
Q3
$4.78M Sell
41,759
-552
-1% -$63.2K 0.37% 95
2020
Q2
$4.75M Sell
42,311
-177
-0.4% -$19.9K 0.4% 89
2020
Q1
$3.82M Sell
42,488
-5,097
-11% -$458K 0.39% 90
2019
Q4
$5.15M Sell
47,585
-7,291
-13% -$788K 0.38% 94
2019
Q3
$5.38M Sell
54,876
-2,705
-5% -$265K 0.4% 87
2019
Q2
$7.54M Sell
57,581
-14,319
-20% -$1.88M 0.52% 83
2019
Q1
$9.72M Buy
71,900
+3,732
+5% +$504K 0.62% 69
2018
Q4
$6.64M Sell
68,168
-7,669
-10% -$747K 0.48% 78
2018
Q3
$10.5M Sell
75,837
-4,381
-5% -$609K 0.58% 72
2018
Q2
$9.96M Sell
80,218
-2,549
-3% -$316K 0.56% 77
2018
Q1
$9.23M Sell
82,767
-1,487
-2% -$166K 0.51% 79
2017
Q4
$10.1M Sell
84,254
-14,265
-14% -$1.71M 0.48% 81
2017
Q3
$13.8M Buy
98,519
+10,338
+12% +$1.45M 0.56% 70
2017
Q2
$10.7M Buy
88,181
+3,556
+4% +$433K 0.34% 85
2017
Q1
$10.3M Buy
84,625
+11,943
+16% +$1.45M 0.34% 80
2016
Q4
$8.89M Buy
72,682
+26,993
+59% +$3.3M 0.29% 78
2016
Q3
$5.6M Sell
45,689
-1,360
-3% -$167K 0.15% 101
2016
Q2
$5.49M Sell
47,049
-162
-0.3% -$18.9K 0.14% 103
2016
Q1
$6.57M Sell
47,211
-656
-1% -$91.3K 0.17% 100
2015
Q4
$9.13M Buy
47,867
+445
+0.9% +$84.9K 0.22% 96
2015
Q3
$7.42M Sell
47,422
-86
-0.2% -$13.5K 0.18% 103
2015
Q2
$8.59M Sell
47,508
-47
-0.1% -$8.5K 0.18% 104
2015
Q1
$8.24M Sell
47,555
-552
-1% -$95.7K 0.18% 107
2014
Q4
$8.9M Sell
48,107
-1,576
-3% -$292K 0.21% 101
2014
Q3
$8.24M Buy
49,683
+35,550
+252% +$5.89M 0.21% 104
2014
Q2
$2.21M Buy
14,133
+12,806
+965% +$2M 0.05% 129
2014
Q1
$202K Buy
+1,327
New +$202K 0.01% 139